PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.\', \'Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.\', \'Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.\', \'Department of Endocrinology, Copenhagen University Hospital, Hvidovre, Denmark.\', \'Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/dom.14329
?:doi
?:hasPublicationType
?:journal
  • Diabetes, obesity & metabolism
is ?:pmid of
?:pmid
?:pmid
  • 33502076
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33502076>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33502076>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all